Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants

Contraception

Volumn 55, Issue 2, 1997, Pages 81-85

  Sivin, Irving ^a   Lähteenmäki, Pekka ^b   Ranta, Sirpa ^b   Darney, Philip ^j   Klaisle, Cindy ^j   Wan, Livia ^c   Mishell Jr , Daniel R ^d   Lacarra, Maria ^d   Viegas, Osborn A C ^e   Bilhareus, Prapas ^f   Koetsawang, Suporn ^f   Piya Anant, Manee ^f   Diaz, Soledad ^g   Pavez, Margarita ^g   Alvarez, Francisco ^h   Brache, Vivian ^h   LaGuardia, Katherine ⁱ   Nash, Harold ^a   Stern, Janet ^a  

^a POPULATION COUNCIL   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c BELLEVUE HOSPITAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f MAHIDOL UNIVERSITY   (Thailand)

^g Instituto Chileno de Medicina Reproductiva   (Chile)

^h Asoc Pro Bienstar de la Familia   (Dominican Republic)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j NONE

more..

Author keywords

contraception; implants; levonorgestrel concentrations; rod implants

Indexed keywords

LEVONORGESTREL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG IMPLANT; FEMALE; HUMAN; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

ACCEPTORS--WOMEN; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE IMPLANTS; CONTRACEPTIVE METHODS; DEMOGRAPHIC FACTORS; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; FAMILY PLANNING PROGRAMS; HEMATOLOGIC TESTS; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; LEVONORGESTREL; POPULATION; POPULATION DYNAMICS; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; TIME FACTORS;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BODY WEIGHT; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; LEVONORGESTREL; PREGNANCY; PREGNANCY RATE; TIME FACTORS;

EID: 0343683454     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(96)00276-4     Document Type: Article

References (6)

1. Sivin I. International experience with Norplant® and Norplant®-2 contraceptives. Stud Fam Plann 1988;19: 81-94.
2. Weiner E, Johansson EDB. Plasma levels of d-norgestrel, estradiol, and progesterone during treatment with Silastic implants containing d-norgestrel. Contraception 1976;14:81-92.
3. Gu S-J, Du M-K, Zhang L-D, Liu Y-L, Wang S-H, Sivin I. A five-year evaluation of Norplant®-II implants in China. Contraception 1994;50:27-34.
4. Indian Council for Medical Research (ICMR), Task Force on Hormonal Contraception: Buckshee K, Chatterjee P, Dhall GI, et al. Phase III clinical trial with Norplant®-II (two covered rods): report on five years of use. Contraception 1993;48:120-32.
5. Olsson S-E, Odlind V, Johansson EDB, Nordstrom M-L. Plasma levels of levonorgestrel and free levonorgestrel index in women using Norplant® implants or two covered rods (Norplant®-2). Contraception 1987;35:215-28.
6. Affandi B, Cekan SZ, Boonasemsanti W, Samil RS, Diczfalusy E. The interaction of sex hormone binding globulin and levonorgestrel released from Norplant®, an implantable contraceptive. Contraception 1987;35:135-45.